Tumor-Acidity and Bioorthogonal Chemistry-Mediated On-Site Size Transformation Clustered Nanosystem to Overcome Hypoxic Resistance and Enhance Chemoimmunotherapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor-Acidity and Bioorthogonal Chemistry-Mediated On-Site Size Transformation Clustered Nanosystem to Overcome Hypoxic Resistance and Enhance Chemoimmunotherapy
Authors
Keywords
-
Journal
ACS Nano
Volume 16, Issue 1, Pages 721-735
Publisher
American Chemical Society (ACS)
Online
2022-01-04
DOI
10.1021/acsnano.1c08232
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Precise Depletion of Tumor Seed and Growing Soil with Shrinkable Nanocarrier for Potentiated Cancer Chemoimmunotherapy
- (2021) Junxia Wang et al. ACS Nano
- D-arginine-loaded metal-organic frameworks nanoparticles sensitize osteosarcoma to radiotherapy
- (2021) Chuanchao Du et al. BIOMATERIALS
- Poly(cyclodextrin)‐Polydrug Nanocomplexes as Synthetic Oncolytic Virus for Locoregional Melanoma Chemoimmunotherapy
- (2020) Jihoon Kim et al. ADVANCED FUNCTIONAL MATERIALS
- Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses
- (2020) Yu Chao et al. Science Advances
- Blockade of Platelets Using Tumor-Specific NO-Releasing Nanoparticles Prevents Tumor Metastasis and Reverses Tumor Immunosuppression
- (2020) Yan Xu et al. ACS Nano
- Transformable Honeycomb‐like Nanoassemblies of Carbon Dots for Regulated Multisite Delivery and Enhanced Antitumor Chemoimmunotherapy
- (2020) Zhihong Nie et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Size-transformable antigen-presenting cell–mimicking nanovesicles potentiate effective cancer immunotherapy
- (2020) Weijing Yang et al. Science Advances
- Oxygenated theranostic nanoplatforms with intracellular agglomeration behavior for improving the treatment efficacy of hypoxic tumors
- (2019) Jun Zhou et al. BIOMATERIALS
- Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade
- (2019) Fangyuan Zhou et al. ADVANCED MATERIALS
- O2 Economizer for Inhibiting Cell Respiration To Combat the Hypoxia Obstacle in Tumor Treatments
- (2019) Wuyang Yu et al. ACS Nano
- Azoreductase-Responsive Metal–Organic Framework-Based Nanodrug for Enhanced Cancer Therapy via Breaking Hypoxia-induced Chemoresistance
- (2019) Caixia Huang et al. ACS Applied Materials & Interfaces
- Enhanced Primary Tumor Penetration Facilitates Nanoparticle Draining into Lymph Nodes after Systemic Injection for Tumor Metastasis Inhibition
- (2019) Jing Liu et al. ACS Nano
- Click chemistry targets antibody-drug conjugates for the clinic
- (2019) Mark Peplow NATURE BIOTECHNOLOGY
- Intratumor Performance and Therapeutic Efficacy of PAMAM Dendrimers Carried by Clustered Nanoparticles
- (2019) Hong-Jun Li et al. NANO LETTERS
- Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies
- (2019) Yun-Chieh Sung et al. Nature Nanotechnology
- Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia
- (2019) Abhishek Sahu et al. BIOMATERIALS
- Hyperbaric Oxygen Potentiates Doxil Antitumor Efficacy by Promoting Tumor Penetration and Sensitizing Cancer Cells
- (2018) Xian Wu et al. Advanced Science
- Nitric oxide as an all-rounder for enhanced photodynamic therapy: Hypoxia relief, glutathione depletion and reactive nitrogen species generation
- (2018) Yongyan Deng et al. BIOMATERIALS
- Oxygen generating nanoparticles for improved photodynamic therapy of hypoxic tumours
- (2017) Yingjie Sheng et al. JOURNAL OF CONTROLLED RELEASE
- Spatial Targeting of Tumor-Associated Macrophages and Tumor Cells with a pH-Sensitive Cluster Nanocarrier for Cancer Chemoimmunotherapy
- (2017) Song Shen et al. NANO LETTERS
- DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
- (2017) Claire Vanpouille-Box et al. Nature Communications
- Smart Superstructures with Ultrahigh pH-Sensitivity for Targeting Acidic Tumor Microenvironment: Instantaneous Size Switching and Improved Tumor Penetration
- (2016) Hong-Jun Li et al. ACS Nano
- Hypoxic tumor microenvironment: Opportunities to develop targeted therapies
- (2016) Akhil Patel et al. BIOTECHNOLOGY ADVANCES
- ABC transporters as mediators of drug resistance and contributors to cancer cell biology
- (2016) Jamie I. Fletcher et al. DRUG RESISTANCE UPDATES
- An Implantable Depot That Can Generate Oxygen in Situ for Overcoming Hypoxia-Induced Resistance to Anticancer Drugs in Chemotherapy
- (2016) Chieh-Cheng Huang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy
- (2016) Hong-Jun Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Role of Micelle Size in Tumor Accumulation, Penetration, and Treatment
- (2015) Jinqiang Wang et al. ACS Nano
- Controllable Generation of Nitric Oxide by Near-Infrared-Sensitized Upconversion Nanoparticles for Tumor Therapy
- (2015) Xiao Zhang et al. ADVANCED FUNCTIONAL MATERIALS
- Nitric oxide producing coating mimicking endothelium function for multifunctional vascular stents
- (2015) Zhilu Yang et al. BIOMATERIALS
- Biomimetic polymers responsive to a biological signaling molecule: Nitric oxide (NO) triggered reversible self-assembly of single macromolecular chains into nanoparticles
- (2015) Jinming Hu et al. JOURNAL OF CONTROLLED RELEASE
- Bioresponsive polymeric nanotherapeutics for targeted cancer chemotherapy
- (2015) Ru Cheng et al. Nano Today
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy
- (2013) M. Weiler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Nitric oxide release: Part II. Therapeutic applications
- (2012) Alexis W. Carpenter et al. CHEMICAL SOCIETY REVIEWS
- Elucidation of the therapeutic enhancer mechanism of poly-S-nitrosated human serum albumin against multidrug-resistant tumor in animal models
- (2012) Yu Ishima et al. JOURNAL OF CONTROLLED RELEASE
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
- (2011) Nadine Rohwer et al. DRUG RESISTANCE UPDATES
- An Ultrasonically Powered Implantable Micro-Oxygen Generator (IMOG)
- (2011) T. Maleki et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- Nitric Oxide Modulates TGF- -Directive Signals To Suppress Foxp3+ Regulatory T Cell Differentiation and Potentiate Th1 Development
- (2011) S.-W. Lee et al. JOURNAL OF IMMUNOLOGY
- Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
- (2011) H. Cabral et al. Nature Nanotechnology
- Tumor delivery of macromolecular drugs based on the EPR effect
- (2010) Vladimir Torchilin ADVANCED DRUG DELIVERY REVIEWS
- Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
- (2009) Ellen M. Sletten et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells
- (2009) Sara De Boo et al. Molecular Cancer
- Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles
- (2009) Zhi Yang et al. NANOTECHNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started